Literature DB >> 18759059

Prevalence and clinical differentiation of dengue fever in children in northern India.

R Kumar1, P Tripathi, S Tripathi, A Kanodia, S Pant, V Venkatesh.   

Abstract

STUDY: Although an increasing trend in outbreaks of dengue infection is seen in the northern Indian plains, the importance of dengue infection as a cause of acute undifferentiated febrile illness (AUFI) round the year is not known and the validity of clinical signs and simple laboratory parameters in differentiating dengue from other causes of AUFI has been sparsely reported.
OBJECTIVES: To study the prevalence of dengue infection as a cause of AUFI seen round the year and validity of clinical and simple laboratory features for its diagnosis.
METHODS: Consecutive children between 6 months and 12 years of age presenting to outpatients on 3 predecided weekdays with complaints of fever of 15 days or less duration and having no localizing signs of infection were enrolled over a 1-year period. Blood counts, liver function tests and ELISA test for dengue IgM were performed besides other investigations. Those testing positive for IgM were considered "probable dengue" (PD) while those with negative IgM tested after 5 days of illness were considered "non-dengue" (ND). Clinico-laboratory features were compared between PD and ND. A randomly selected subsample of IgM +ves was tested for dengue genome by real time PCR assay.
RESULTS: Of 298 children enrolled over 1 year, 56 (18.8%) tested positive for dengue IgM and 132 were ND. Comparing PD and ND, age, duration of illness at presentation, rash, bleeding manifestations, vomiting, platelet count, liver transaminases, serum proteins, albumen and bilirubin were significant features on univariate analysis. On logistic regression younger age, rash and higher serum alanine transaminase (sALT) levels were the only significant independent predictors for PD. Taking cutoff of age as 60 months or less and sALT > 40 units, one or more of these features were seen in 50/56 PD cases (sensitivity 89.3%). All of these were present in only 1 of 132 ND cases (specificity 99.2%). Randomly selected 44 of the 56 IgM +ve patients were subjected to PCR assay, of which 15 were positive.
CONCLUSIONS: Dengue transmission occurs round the year in this region. The cause of AUFI was definitely dengue in 15/298, i.e., 5% cases and likely to be dengue in another 13.8% cases. In children presenting to outpatients here with AUFI, young age, rash, and raised sALT are significant independent pointers to dengue. A combination of clinical and laboratory features including liver enzymes could be used to achieve high sensitivity and specificity. These results should be validated in a separate data set.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759059     DOI: 10.1007/s15010-008-7172-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Characteristics of mild dengue virus infection in Thai children.

Authors:  In-Kyu Yoon; Anon Srikiatkhachorn; Laura Hermann; Darunee Buddhari; Thomas W Scott; Richard G Jarman; Jared Aldstadt; Ananda Nisalak; Suwich Thammapalo; Piraya Bhoomiboonchoo; Mammen P Mammen; Sharone Green; Robert V Gibbons; Timothy P Endy; Alan L Rothman
Journal:  Am J Trop Med Hyg       Date:  2013-10-14       Impact factor: 2.345

2.  Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area--Puerto Rico, 2007-2008.

Authors:  Christopher J Gregory; Luis Manuel Santiago; D Fermin Argüello; Elizabeth Hunsperger; Kay M Tomashek
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  A protocol for the emergency department management of acute undifferentiated febrile illness in India.

Authors:  Sudhagar Thangarasu; Piruthiviraj Natarajan; Parivalavan Rajavelu; Arjun Rajagopalan; Jeremy S Seelinger Devey
Journal:  Int J Emerg Med       Date:  2011-09-05

4.  Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room.

Authors:  Shi-Yu Huang; Ing-Kit Lee; Lin Wang; Jien-Wei Liu; Shih-Chiang Hung; Chien-Chih Chen; Tzu-Yao Chang; Wen-Chi Huang
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

5.  Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features.

Authors:  Shyam Prakash Dumre; Renu Bhandari; Geeta Shakya; Sanjaya Kumar Shrestha; Mahamoud Sama Cherif; Prakash Ghimire; Chonticha Klungthong; In-Kyu Yoon; Kenji Hirayama; Kesara Na-Bangchang; Stefan Fernandez
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

6.  The clinical differences between dengue and scrub typhus with acute respiratory failure in southern Taiwan.

Authors:  H-C Chang; M-C Lin; S-F Liu; M-C Su; W-F Fang; Y-C Chen; C-C Tseng; C-H Lai; K-T Huang; C-C Wang
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

7.  Tropical Diseases on Insurgence: Clinician's Perspective.

Authors:  Partha Chatterjee; Nilendu Sarma; Sushila Hansda
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

Review 8.  Dengue infection in India: A systematic review and meta-analysis.

Authors:  Parasuraman Ganeshkumar; Manoj V Murhekar; Veeraraghavadoss Poornima; Velusamy Saravanakumar; Krishnendu Sukumaran; Anandan Anandaselvasankar; Denny John; Sanjay M Mehendale
Journal:  PLoS Negl Trop Dis       Date:  2018-07-16

9.  Development of standard clinical endpoints for use in dengue interventional trials.

Authors:  Kay M Tomashek; Bridget Wills; Lucy Chai See Lum; Laurent Thomas; Anna Durbin; Yee-Sin Leo; Norma de Bosch; Elsa Rojas; Kim Hendrickx; Martin Erpicum; Liane Agulto; Thomas Jaenisch; Hasitha Tissera; Piyarat Suntarattiwong; Beth Ann Collers; Derek Wallace; Alexander C Schmidt; Alexander Precioso; Federico Narvaez; Stephen J Thomas; Robert Edelman; João Bosco Siqueira; M Cristina Cassetti; Walla Dempsey; Duane J Gubler
Journal:  PLoS Negl Trop Dis       Date:  2018-10-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.